262 related articles for article (PubMed ID: 25885449)
1. YY1 suppresses FEN1 over-expression and drug resistance in breast cancer.
Wang J; Zhou L; Li Z; Zhang T; Liu W; Liu Z; Yuan YC; Su F; Xu L; Wang Y; Zhou X; Xu H; Hua Y; Wang YJ; Zheng L; Teng YE; Shen B
BMC Cancer; 2015 Feb; 15():50. PubMed ID: 25885449
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-140 impedes DNA repair by targeting FEN1 and enhances chemotherapeutic response in breast cancer.
Lu X; Liu R; Wang M; Kumar AK; Pan F; He L; Hu Z; Guo Z
Oncogene; 2020 Jan; 39(1):234-247. PubMed ID: 31471584
[TBL] [Abstract][Full Text] [Related]
3. Targeting DNA Flap Endonuclease 1 to Impede Breast Cancer Progression.
He L; Zhang Y; Sun H; Jiang F; Yang H; Wu H; Zhou T; Hu S; Kathera CS; Wang X; Chen H; Li H; Shen B; Zhu Y; Guo Z
EBioMedicine; 2016 Dec; 14():32-43. PubMed ID: 27852524
[TBL] [Abstract][Full Text] [Related]
4. Curcumin inhibits proliferation of breast cancer cells through Nrf2-mediated down-regulation of Fen1 expression.
Chen B; Zhang Y; Wang Y; Rao J; Jiang X; Xu Z
J Steroid Biochem Mol Biol; 2014 Sep; 143():11-8. PubMed ID: 24486718
[TBL] [Abstract][Full Text] [Related]
5. Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1.
Wang Y; Li S; Zhu L; Zou J; Jiang X; Chen M; Chen B
Clin Transl Oncol; 2019 Aug; 21(8):1026-1033. PubMed ID: 30712236
[TBL] [Abstract][Full Text] [Related]
6. PRMT1 is critical to FEN1 expression and drug resistance in lung cancer cells.
He L; Hu Z; Sun Y; Zhang M; Zhu H; Jiang L; Zhang Q; Mu D; Zhang J; Gu L; Yang Y; Pan FY; Jia S; Guo Z
DNA Repair (Amst); 2020 Nov; 95():102953. PubMed ID: 32861926
[TBL] [Abstract][Full Text] [Related]
7. Overexpression and hypomethylation of flap endonuclease 1 gene in breast and other cancers.
Singh P; Yang M; Dai H; Yu D; Huang Q; Tan W; Kernstine KH; Lin D; Shen B
Mol Cancer Res; 2008 Nov; 6(11):1710-7. PubMed ID: 19010819
[TBL] [Abstract][Full Text] [Related]
8. FEN1 promotes tumor progression and confers cisplatin resistance in non-small-cell lung cancer.
He L; Luo L; Zhu H; Yang H; Zhang Y; Wu H; Sun H; Jiang F; Kathera CS; Liu L; Zhuang Z; Chen H; Pan F; Hu Z; Zhang J; Guo Z
Mol Oncol; 2017 Jun; 11(6):640-654. PubMed ID: 28371273
[TBL] [Abstract][Full Text] [Related]
9. Interaction between APC and Fen1 during breast carcinogenesis.
Narayan S; Jaiswal AS; Law BK; Kamal MA; Sharma AK; Hromas RA
DNA Repair (Amst); 2016 May; 41():54-62. PubMed ID: 27088617
[TBL] [Abstract][Full Text] [Related]
10. Genomic and protein expression analysis reveals flap endonuclease 1 (FEN1) as a key biomarker in breast and ovarian cancer.
Abdel-Fatah TM; Russell R; Albarakati N; Maloney DJ; Dorjsuren D; Rueda OM; Moseley P; Mohan V; Sun H; Abbotts R; Mukherjee A; Agarwal D; Illuzzi JL; Jadhav A; Simeonov A; Ball G; Chan S; Caldas C; Ellis IO; Wilson DM; Madhusudan S
Mol Oncol; 2014 Oct; 8(7):1326-38. PubMed ID: 24880630
[TBL] [Abstract][Full Text] [Related]
11. Endonuclease FEN1 Coregulates ERα Activity and Provides a Novel Drug Interface in Tamoxifen-Resistant Breast Cancer.
Flach KD; Periyasamy M; Jadhav A; Dorjsuren D; Siefert JC; Hickey TE; Opdam M; Patel H; Canisius S; Wilson DM; Donaldson Collier M; Prekovic S; Nieuwland M; Kluin RJC; Zakharov AV; Wesseling J; Wessels LFA; Linn SC; Tilley WD; Simeonov A; Ali S; Zwart W
Cancer Res; 2020 May; 80(10):1914-1926. PubMed ID: 32193286
[TBL] [Abstract][Full Text] [Related]
12. miR-218 targets survivin and regulates resistance to chemotherapeutics in breast cancer.
Hu Y; Xu K; Yagüe E
Breast Cancer Res Treat; 2015 Jun; 151(2):269-80. PubMed ID: 25900794
[TBL] [Abstract][Full Text] [Related]
13. FEN1 Inhibition as a Potential Novel Targeted Therapy against Breast Cancer and the Prognostic Relevance of FEN1.
Berfelde J; Hildebrand LS; Kuhlmann L; Fietkau R; Distel LV
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396787
[TBL] [Abstract][Full Text] [Related]
14. FEN1 mediates miR-200a methylation and promotes breast cancer cell growth
Zeng X; Qu X; Zhao C; Xu L; Hou K; Liu Y; Zhang N; Feng J; Shi S; Zhang L; Xiao J; Guo Z; Teng Y; Che X
FASEB J; 2019 Oct; 33(10):10717-10730. PubMed ID: 31266372
[TBL] [Abstract][Full Text] [Related]
15. Jianpi-yangwei decoction inhibits DNA damage repair in the drug resistance of gastric cancer by reducing FEN1 expression.
Huang W; Tang H; Wen F; Lu X; Li Q; Shu P
BMC Complement Med Ther; 2020 Jun; 20(1):196. PubMed ID: 32586310
[TBL] [Abstract][Full Text] [Related]
16. Association of functional FEN1 genetic variants and haplotypes and breast cancer risk.
Lv Z; Liu W; Li D; Liu L; Wei J; Zhang J; Ge Y; Wang Z; Chen H; Zhou C; Yuan Q; Zhou L; Yang M
Gene; 2014 Mar; 538(1):42-5. PubMed ID: 24440783
[TBL] [Abstract][Full Text] [Related]
17. Role of Yin Yang-1 (YY1) in the transcription regulation of the multi-drug resistance (
Antonio-Andrés G; Rangel-Santiago J; Tirado-Rodríguez B; Martinez-Ruiz GU; Klunder-Klunder M; Vega MI; Lopez-Martinez B; Jiménez-Hernández E; Torres Nava J; Medina-Sanson A; Huerta-Yepez S
Leuk Lymphoma; 2018 Nov; 59(11):2628-2638. PubMed ID: 29616858
[TBL] [Abstract][Full Text] [Related]
18. The role of YY1 in reduced HP1alpha gene expression in invasive human breast cancer cells.
Lieberthal JG; Kaminsky M; Parkhurst CN; Tanese N
Breast Cancer Res; 2009; 11(3):R42. PubMed ID: 19566924
[TBL] [Abstract][Full Text] [Related]
19. FEN1 endonuclease as a therapeutic target for human cancers with defects in homologous recombination.
Guo E; Ishii Y; Mueller J; Srivatsan A; Gahman T; Putnam CD; Wang JYJ; Kolodner RD
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19415-19424. PubMed ID: 32719125
[TBL] [Abstract][Full Text] [Related]
20. RKIP-mediated chemo-immunosensitization of resistant cancer cells via disruption of the NF-κB/Snail/YY1/RKIP resistance-driver loop.
Bonavida B
Crit Rev Oncog; 2014; 19(6):431-45. PubMed ID: 25597353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
